Dr. Jonathan Li reviews the prevalence of BQ.1, BQ.1.1, and other viral variants in November 2022, implications of these variants, and potential changes to COVID-19 treatment and prevention. Immunocompromised patients will be disproportionally affected by any changes to treatment and prevention.
View this program in its entirety: [ Ссылка ]
Covid-19 CME activities you may be interested in:
A Call to Action: Monoclonal Antibodies for the Prevention and Treatment of COVID-19
[ Ссылка ]
Monoclonal Antibodies For COVID-19
An Update on Best Practices
[ Ссылка ]
Are You Up to Date on COVID-19 Diagnosis and Treatment Guidelines?
[ Ссылка ]
ExchangeCME.com is an online community of more than 45,000 active healthcare professionals who have access to a variety of enduring educational activities and other disease state–focused resources. The Website’s core mission is to support patient-centered care via education that is tailored to the needs of various clinician audiences.
By consolidating evidence-based resources and hosting only accredited educational programs without any promotional content or advertising, ExchangeCME.com serves as an independent, trusted, and balanced source of free CME/CE for physicians, nurses, pharmacists, and other healthcare providers.
Follow us on social media!
Twitter: [ Ссылка ]
Facebook: [ Ссылка ]
Linkedin: [ Ссылка ]
#omicron #covid19 #covid #news #breakingnews #variants #covid19news #antibodies #cme #meded
